MTOR and glioblastoma: Future studies to better understand the subtype selective PI3Kα dependencies in GSCs, as well as additional preclinical studies using dual PI3Kα/mTOR inhibition in orthotopic patient-derived xenograft (PDX) models may have important clinical-translational implications for the treatment of GBM.